Es investigacin preclnica (modelos animales)
It is not intended for human or animal use and must not be used for medical, therapeutic, diagnostic, or consumption purposes
Other Peptide Therapies Besides BPC 157/TB 500, additional peptide therapy is available with Dr
For those interested in exploring the benefits of these peptides, Information Hub offers resources and support services to help individuals make informed decisions about their recovery options
Additional at-risk groups include: Vegans and strict vegetarians , who may have low dietary B12 intake People with autoimmune conditions , including pernicious anaemia or type 1 diabetes Individuals with gastrointestinal conditions such as Crohn's disease or coeliac disease, which impair nutrient absorption People who have undergone bariatric surgery , which can significantly reduce B12 absorption Long-term users of proton pump inhibitors (PPIs) or H2-receptor antagonists , which reduce gastric acid and impair B12 release from food Those with a family history of either pernicious anaemia or diabetes For these groups, simultaneous monitoring of B12 status and glycaemic markers is particularly important to avoid diagnostic errors